Rincon Bio performs Raji xenograft models to test efficacy of preclinical therapies. Please see below for additional information or to request a quote.
Raji cells were derived from an 11 year old make with Burkitt's lymphoma
Used in xenografts to test the efficacy of novel cancer therapeutics. Tumors develop after being injected into the flank of immunocompromised mice.
Rincon Bio Growth Curve
Cell Line: Raji
Mouse Strain: NOD.CB17 Prkdc<Scid>NCrHsd from Envigo
Positive Control: Rituximab, Trastuzumab
Dosing: One dose, tail vein
From implant to stratification: 47 days
Cells Implanted per Animal: 10 million
WHY WORK WITH
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
Most efficacy studies can be initiated within two business days.
We love our clients! We are flexible and easy to work with. And we take a personal interest in our clients' studies.